Clinical Trials

An Open-Label Phase 2 Proof-of-Concept Study in Patients with C3 Glomerulopathy (C3G) or Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN) Treated with ACH-0144471


Research Study Number:
PRO 2018-0007

Short Title:
ACH471-205

Division:
Nephrology

Study Status:
Pending